Global Molecular Influenza Diagnostic Market Size, Status and Forecast 2020-2026

Molecular assays are a new type of molecular influenza diagnostic test to detect influenza viral RNA or nucleic acids in upper respiratory tract specimens in approximately 15-30 minutes.
Market Analysis and Insights: Global Molecular Influenza Diagnostic Market
In 2019, the global Molecular Influenza Diagnostic market size was US$ xx million and it is expected to reach US$ xx million by the end of 2026, with a CAGR of xx% during 2020-2026.
Global Molecular Influenza Diagnostic Scope and Market Size
Molecular Influenza Diagnostic market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Molecular Influenza Diagnostic market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Segment by Type, the Molecular Influenza Diagnostic market is segmented into Reverse Transcription Polymerase Chain Reaction (RT-PCR), Nucleic Acid Sequence Based Amplification (NASBA) Tests, Loop-mediated Isothermal Amplification-Based Assays (LAMP), Simple Amplification-based Assays (SAMBA), etc.
Segment by Application, the Molecular Influenza Diagnostic market is segmented into Hospitals, POCT, Others, etc.
Regional and Country-level Analysis
The Molecular Influenza Diagnostic market is analysed and market size information is provided by regions (countries).
The key regions covered in the Molecular Influenza Diagnostic market report are North America, Europe, China, Japan, Southeast Asia, India and Central & South America, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of revenue for the period 2015-2026.

Competitive Landscape

and Molecular Influenza Diagnostic Market Share Analysis
Molecular Influenza Diagnostic market competitive landscape provides details and data information by vendors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by player for the period 2015-2020. Details included are company description, major business, company total revenue and the revenue generated in Molecular Influenza Diagnostic business, the date to enter into the Molecular Influenza Diagnostic market, Molecular Influenza Diagnostic product introduction, recent developments, etc.
The major vendors include BD, Abbott (Include Alere), Roche, SIEMENS, Analytik Jena, Quidel, Thermo Fisher, Meridian Bioscience, BioMerieux, Sekisui Diagnostics, Response Biomedical, SA Scientific, etc.

This report focuses on the global Molecular Influenza Diagnostic status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Molecular Influenza Diagnostic development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study

BD
Abbott (Include Alere)
Roche
SIEMENS
Analytik Jena
Quidel
Thermo Fisher
Meridian Bioscience
BioMerieux
Sekisui Diagnostics
Response Biomedical
SA Scientific

Market segment by Type, the product can be split into

Reverse Transcription Polymerase Chain Reaction (RT-PCR)
Nucleic Acid Sequence Based Amplification (NASBA) Tests
Loop-mediated Isothermal Amplification-Based Assays (LAMP)
Simple Amplification-based Assays (SAMBA)

Market segment by Application, split into

Hospitals
POCT
Others

Market segment by Regions/Countries, this report covers

North America
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:

To analyze global Molecular Influenza Diagnostic status, future forecast, growth opportunity, key market and key players.
To present the Molecular Influenza Diagnostic development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Molecular Influenza Diagnostic are as follows:
History Year: 2015-2019

Base Year:

2019

Estimated Year:

2020
Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.